hematopoietic and lymphoid cell neoplasm
Showing 1 - 25 of 153
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Supportive Care, Survey
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Best Practice
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 17, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Educational Intervention, Interview, Survey
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Educational Intervention
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 25, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Health Promotion and Education
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 24, 2023
Toxicities on Health During Cancer
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Assessment of Therapy Complications
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 16, 2023
Childhood Cancer, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in San Francisco (Survivorship mobile
Recruiting
- Childhood Cancer
- +2 more
- Survivorship mobile application
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 1, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Letermovir)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Letermovir
- (no location specified)
Jan 23, 2023
Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)
Recruiting
- Advanced Malignant Solid Neoplasm
- +15 more
- Biospecimen Collection
- Nivolumab
-
Birmingham, Alabama
- +46 more
Jan 31, 2023
Hematopoietic and Lymphoid Cell Tumor, Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (Supportive
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Supportive Palliative Care
- +6 more
-
Palo Alto, California
- +8 more
Jan 30, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Canada, United States (other, device, behavioral)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Educational Intervention
- +5 more
-
Mobile, Alabama
- +110 more
Jan 30, 2023
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Testing for Chronic Graft Versus Host Disease, CATCH Study
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Biospecimen Collection
- +6 more
-
Gainesville, Florida
- +6 more
Jan 25, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Vincristine
-
Birmingham, Alabama
- +20 more
Jan 23, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Philadelphia (Magnetic Resonance Imaging, Computed
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Magnetic Resonance Imaging
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023
Molecular Testing for MD Anderson Cancer Center Personalized
Recruiting
- Glioma
- +4 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Role of Gut Microbiome in Cancer Therapy
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 18, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Nasal Vestibulitis Trial in United States (Placebo Administration,
Completed
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Placebo Administration
- +2 more
-
Albert Lea, Minnesota
- +19 more
Jan 18, 2023
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (6 Minute Walk Functional Test, Behavioral
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- 6 Minute Walk Functional Test
- +3 more
-
Houston, Texas
- +1 more
Jan 6, 2023
Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Rochester (Olanzapine, Placebo Administration,
Recruiting
- Advanced Malignant Solid Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
- Olanzapine
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +13 more
- CMVpp65-A*0201 peptide vaccine
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +6 more
- Omacetaxine Mepesuccinate
- Venetoclax
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Collecting Blood and Tissue Sample Donations for Research for
Not yet recruiting
- Anal Carcinoma
- +11 more
- Biospecimen Collection
- (no location specified)
Dec 21, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Itacitinib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 20, 2022
Nutritional Interventions Among Cancer Patients
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Interview
- Survey Administration
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Dec 13, 2022
Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)
Recruiting
- Hematologic and Lymphocytic Disorder
- Hematopoietic and Lymphoid Cell Neoplasm
- Placebo Administration
- +3 more
-
Duarte, California
- +3 more
Dec 14, 2022